The main purpose of this inventory is to serve as a reference to help stakeholders working in the pharmaceutical sector easily access and use already available SIAPS resources, including tools, experiences, and results. The document is also intended to serve as a technical legacy for SIAPS to support knowledge exchange and sustainability of related work. … Read more
SIAPS final report showcases achievements across 46 countries. Interventions are described by intermediate results and health areas and demonstrate how SIAPS successfully worked with a range of stakeholders, including Ministries of Health, to bolster pharmaceutical systems and address country-specific needs.
The SIAPS-developed AMR coalition-based strategy identifies educational institutions, such as UNAM; therapeutic committees (TCs); and key institutions involved in AMR, such as the National Institute of Pathology (NIP) as key players in the pre- and in-service training of health care professionals to enhance RMU and combat AMR. SIAPS collaborated with key institutions, including the MoHSS, … Read more
The US Ambassador to Namibia, H.E. Thomas F. Daughton, launched CBART group ARV refills on June 1, 2017. These groups are implemented widely in Onandjokwe and other districts in northern Namibia, where the HIV burden is high. During the CBART group ARV refill initiative launch, the ambassador remarked “simple solutions = best solutions; bring the … Read more
Antimicrobial resistance (AMR) occurs when a microorganism becomes resistant to a drug that was originally effective for treating the infections it caused. It is one of the world’s most pressing global health threats and could erode progress made thus far in the treatment of HIV/AIDS, TB, malaria, and many other infectious diseases. Management Sciences for … Read more
SIAPS has been proactive in supporting Swaziland in various areas of the pharmaceutical sector, which has contributed to the containment of antimicrobial resistance. During the process of developing the National AMR Containment Strategic Plan, the stakeholders and the AMR committee have learned valuable lessons—in particular, the importance of the One Health approach, as well as the … Read more
By Francis Aboagye-Nyame, SIAPS program director Greatjoy Mazibuko was a pharmacist at the Oshakati Intermediate Hospital in Namibia working with ART patients. Every day, he rose at dawn, not knowing how many patients he would have that day. He often worked for 12 hours or more; patients were kept waiting for hours, perhaps having traveled … Read more
A presentation by Mohan P. Joshi, Principal Technical Advisor and Lead for Pharmaceutical Services, SIAPS. Presented at a side event during the 2018 Prince Mahidol Awards Conference on the theme “Monitoring and Improving Medicines Quality through AMR National Action Plans”, organized by USP, USAID, the Thai Food and Drug Authority, and the Thai Department of … Read more
SIAPS Final Report showcases achievements across 46 countries. Interventions are described by intermediate results and health areas and demonstrate how SIAPS successfully worked with a range of stakeholders, including Ministries of Health, to bolster pharmaceutical systems and address country-specific needs. [button style=”download” link=”https://siapsprogram.org/wp-content/uploads/2018/03/SIAPS-End-of-Program-Report.pdf” color=”silver”]Download this file as a PDF[/button]
On Thursday, March 1, 2018, MSH held an end-of-program event for the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program. More than 100 attendees gathered in Arlington, VA, to discuss progress made and opportunities toward ensuring that quality, life-saving essential medicines and services are available and affordable for the world’s poorest and … Read more
